50 ml tirzepatide New clinical trial: Zepbound (tirzepatide) helped adults lose an average of 20.2% of their body weight—around lbs—over 72 weeks, outperforming Wegovy's 13.7% (~33 lbs). Credit to: https://www.healthline.com/health-news/zepbound-wegovy-weight-loss 199.00 | Tirzepatide --- 50

Epigenetic regulation in human melanoma: past and future

While there is no documented evidence directly linking GLP-1 medications to increased sex drive, Katie Sorensen, FNP-C, explains that with the reduction of body fat from losing weight using a GLP-1, men and womens estrogen levels can go down, allowing testosterone to be more active

GLP-3 RT (RETATRUTIDE) Description: GLP-3 RT (Retatrutide) is an investigational unimolecular triple agonist of the glucagon-like peptide-1 receptor (GLP-1R), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon receptor (GCGR)

However, some people may experience mild side effects such as stomach upset, diarrhoea, and allergic reactions

The trick

For many, the health benefits of weight reduction and resolving dangerous comorbidities such as sleep apnea and diabetes make it worthwhile to try a GLP-1, despite the possible risks